HALO
Halozyme Therapeutics Inc
109.80$
-0.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.99 | 0.78 | 1.00 | 0.43 | 0.89 | 1.38 | 1.22 | 0.80 | 1.46 | 1.86 | 1.47 | 1.99 | 6.75 | |
| 0.17 | 0.17 | 0.17 | 0.17 | 0.16 | 0.17 | 0.16 | 0.18 | 0.17 | 0.23 | 0.27 | 0.28 | 0.95 | |
| 0.07 | 0.07 | 0.08 | 0.07 | 0.10 | 0.09 | 0.08 | 0.10 | 0.10 | 0.14 | 0.14 | 0.15 | 0.52 | |
| 0.05 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.18 | -0.13 | 0.02 | -0.65 | -0.41 | -0.19 | 0.06 | -0.50 | -0.42 | -0.08 | -0.21 | -0.36 | -1.08 | |
| 0.02 | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0.03 | 0.03 | 0.10 | |
| -0.62 | -0.06 | -0.64 | -0.33 | -1.29 | 0.23 | -0.71 | 0.68 | 1.65 | -6.30 | -0.02 | -0.52 | -5.00 | |
| – | 0.10 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.00 | -1.93 | 0.00 | 0.00 | 0.00 | -1.93 | – | -2.42 | -0.32 | 0.00 | – | -2.74 | – | |
| – | – | – | – | 0.00 | 0.00 | – | – | – | – | – | – | – | |
| 0.03 | -1.91 | 0.00 | 0.07 | 0.14 | -1.90 | -0.03 | -2.41 | -0.18 | 2.04 | -0.01 | -2.69 | -0.91 | |
| 0.40 | -1.19 | 0.36 | 0.18 | -0.26 | -0.30 | 0.48 | -0.92 | 2.92 | -2.43 | 1.43 | -1.22 | 0.82 | |
| 0.97 | 0.76 | 0.98 | 0.41 | 0.87 | 1.36 | 1.21 | 0.79 | 1.44 | 1.85 | 1.44 | 1.95 | 6.65 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.